Study of G-CSF for DOR in Patients Undergoing IVF

Conditions: Diminished Ovarian Reserve, IVF, G-CSF, Granulocyte Colony Stimulating Factor

Sex: Female

Ages: 35 Years – 44 Years

Healthy volunteers: No

Phase: PHASE4

Enrollment: 140

Sponsor: Center for Human Reproduction

Summary

Diminished ovarian reserve (DOR) is defined by reduced follicle counts in women, associated with decreased fertility and lower success rates with In Vitro Fertilization (IVF). Granulocyte Colony Stimulating Factor (G-CSF) is a medication that has been proposed as a potential treatment for DOR, as it may help to improve ovarian function and increase the number of mature eggs available for fertilization. However, the efficacy and safety of G-CSF for DOR in IVF patients have not been definitively established. Therefore, our research protocol aims to assess the effectiveness of G-CSF in improving IVF outcomes in patients with DOR in POSEIDON group 4 (age ≥35 years and AMH \

Eligibility Criteria

Inclusion Criteria: * Infertile women aged 35-44 years who have indication to undergo IVF and meet the POSEIDON group 4 (DOR): FSH \1.2 ng/mL * Participants will be recruited from patients undergoing IVF treatment at The CHR

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07871825). StuddyBuddy aggregates publicly available trial information.